Mirai Bio Presents Data Showing Rapid Advancement of Novel CD8+ T-Cell Targeted LNPs to Functional NHP Proof-of-Concept at ASGCT 2026

AI Briefing

• – Mirai Bio presents data on novel CD8+ T-cell targeted LNPs
• – Rapid advancement to functional NHP proof-of-concept at ASGCT 2026
• – Company makes significant progress in immunotherapy development